Patent · US Expired

Derivatives of 5-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, the preparation thereof and the application of same in therapeutics

US7223750B2 · kind B2 · utility

3Cited by
3References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 3, 2003
Grant dateMay 29, 2007
Priority date
Expiry dateJul 10, 2023

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P25/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds complying with the general formula (I)in which R either represents a halogen atom or a phenyl group substituted by one or more groups chosen from halogen atoms and (C1–C6)alkyl, (C1–C6)alkoxy, nitro, amino, trifluoromethyl, cyano, hydroxy, acetyl or methylenedioxy groups, or represents a pyridinyl group, a thienyl group, an indolyl group, or a pyrimidinyl group optionally substituted by one or more (C1–C6)alkoxy groups, where, of the two carbon-carbon bonds represented by , one is single and the other may be single or double.Therapeutic application.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.